BioMarin Pharmaceutical Inc BMRN

lauralea Pro

Possibly a bottom formed, time will tell. 3 year high is 131.95 and 3 year low is 62.88. ATH is 151.75 but price gapped down dramatically from this level in the past. The top appears to have been in a rectangle that broke to the downside. The bottom trendline of the rectangle is now resistance. The resistance of that bottom trendline has knocked price away...

Therealbouga Pro

BMRN. Bullish Gartley. Target 1: 81.89

bravo102

NASDAQ:BMRN Title. I have puts on this for the short time (green so far) - not expecting crazy gains

bravo102

NASDAQ:BMRN Feeling red for this - looking into april puts

dafster17 Premium

BMRN is looking good again here holding trend while shaping up a very nice coil coming into apex. Massive gap overhead remains.

PennantTrading Pro

Watching for a breakout

Jahcreamer Pro

I am a yung colored entrepreneur

RedHotStocks

Potential entry above $81.00 Target price $85.75

RocketTickers

BMRN: BioMarin Pharmaceutical Inc. 2020-10-07 08:31:00 BioMarin, Pioneer in Rare Disease Treatments for Phenylketonuria (PKU), Receives FDA Approval of Label Expansion to Allow Maximum Dose of 60 mg for Palynziq® (pegvaliase-pqpz) Injection for Treatment of Adults with PKU

BlockTechEv

BMRN selloff seems to be over and this is a possible entry point, some resistance at 80 but if we breach 80 we might se 88 shortly after. Very volatile market. Your thoughts.. is this a stock worth investing in? Stay safe, Ev

ripster47 Premium

Downside Risk 76

Crypto_Curry

We have hit a multi-decade trendline, so I don't know about you, but I'm in.

hasannaser Updated 

Will Buy With Cearful

JustTradewithme

Biomarin @ Buy Point # Trend Line # Supply and Demand Zone # Monthly Low # Monthly Retracement

clovers7 Pro

#BMRN BIOMARIN LONG-TERM INVESTMENT

gary_trades Pro+

BioMarin Pharmaceutical (BMRM) has gone up in 3 waves since the March crash and has been bouncing off the current support level for the past week. This support line is 100% from 1st wave and 61% from wave two. They have their trial drug BMN 270 for rare genetic disease Hemophilia A under priority review with FDA and expected action date of 21st August. (refer...

EWFcw Pro

Biomarin Pharmaceutical Inc (BMRN - NASDAQ) has two different count, where either it already ended impulse as shown by roman letter, or its within 3rd wave cycle as shown in green roman letter. It is in 3rd internal wave of 5th subwave of 3rd wave, so stay bullish above 124.65 for the new high around 136-140 level.

Essendy Pro+

3 bar play breakout above $125. Target is July 2015 highs. Still not too late to get in.